Acotec Scientific (HKG:6669) obtained registration approval for the sirolimus-coated coronary balloon dilatation catheter AcoArt Canna from China's National Medical Products Administration, a Monday Hong Kong bourse filing said.
AcoArt Cannais indicated for the dilatation treatment of de novo coronary artery bifurcation lesions.